Key Insights

Highlights

Success Rate

83% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 49/100

Termination Rate

6.3%

1 terminated out of 16 trials

Success Rate

83.3%

-3.2% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

40%

2 of 5 completed with results

Key Signals

2 with results83% success

Data Visualizations

Phase Distribution

8Total
Not Applicable (4)
P 2 (4)

Trial Status

Completed5
Recruiting5
Not Yet Recruiting3
Unknown2
Terminated1

Trial Success Rate

83.3%

Benchmark: 86.5%

Based on 5 completed trials

Clinical Trials (16)

Showing 16 of 16 trials
NCT07216209Not ApplicableRecruitingPrimary

The Impact of Exercise on the Tumor Microenvironment in Patients With Lung Cancer

NCT05077709Phase 2CompletedPrimary

IO102-IO103 in Combination With Pembrolizumab as First-line Treatment for Patients With Metastatic NSCLC, SCCHN, or mUBC

NCT07405190Phase 2Not Yet Recruiting

Ivonescimab Alone And With Carboplatin/Pemetrexed For NSCLC

NCT06872489Unknown

Expanded Access Protocol for the Use of SL-28 in the Treatment of Advanced Solid Tumors

NCT06926790Phase 2RecruitingPrimary

Neoadjuvant Nivolumab Plus Ipilimumab in Resectable NSCLC (GALAXY 3)

NCT06908005CompletedPrimary

RaFIST: A Radiomics-Based Tool for Intratumoral Fibrosis Stratification in Non-Small Cell Lung Cancer

NCT06889467Recruiting

Liquid Biopsy Assay of EBUS-TBNA Supernatant Fluid for Diagnosing Lung Cancer

NCT06659458RecruitingPrimary

Utilizing Long-read Sequencing to Investigate the EGFR Landscape of EGFR Positive Lung Cancer Patients

NCT06786468Not ApplicableRecruitingPrimary

Standard Care With or Without Early Palliative Care Provided by Palliative Care Specialist in Advanced Non-small Cell Lung Cancer Patients

NCT06725537Not Yet RecruitingPrimary

Comprehensive Demographics and Clinical Profile of NSCLC Patients

NCT06737367CompletedPrimary

Integrating Machine Learning for Prognostic Prediction in Stage I NSCLC by CT Images and Pathological Factors

NCT06679712Not ApplicableNot Yet RecruitingPrimary

Transbroncheal Novel PDT Peripheral Lung Tumor Ablation With 5-ALA

NCT06621147CompletedPrimary

Application of Machine Learning Algorithms to Identify Optimal Candidates for Primary Tumor Resection in Patients with Metastatic Non-small Cell Neuroendocrine Tumors

NCT06161935CompletedPrimary

A Study of Lymph Node Metastatic Pattern Based Incorporating Tumor Location, GGO Components and Size for Non-small Cell Lung Cancer

NCT04669730Not ApplicableUnknownPrimary

Baduanjin Exercise on Meridian Energy, Lung Function and Heart Rate Variability in Patients Undergoing Lung Operative.

NCT01471197Phase 2TerminatedPrimary

Safety and Efficacy Trial of Ipilimumab Versus Pemetrexed in Non-Squamous Non-Small Cell Lung Cancer

Showing all 16 trials

Research Network

Activity Timeline